InMode to Present at Upcoming Investor Conferences

Rhea-AI Summary

InMode (Nasdaq: INMD), a leading global provider of innovative medical technologies, has announced its participation in two upcoming investor conferences in August 2024. The company will be present at the 9th Annual Needham Virtual MedTech & Diagnostics Conference on August 12, with CEO Moshe Mizrahy and CFO Yair Malca conducting virtual one-on-one meetings. Additionally, CFO Yair Malca will participate in the Canaccord 44th Annual Global Growth Conference on August 14 at 2:00 pm ET, featuring an in-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, along with meetings. A live webcast of the Canaccord presentation will be available for interested parties.

News Market Reaction

+2.61%

1 alert

+2.61% News Effect

On the day this news was published, INMD gained 2.61%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

YOKNEAM, Israel, Aug. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in August:

9^th Annual Needham Virtual MedTech & Diagnostics Conference

Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer
Format: Virtual one-on-one meetings
When: Monday, Aug. 12

Canaccord 44^th Annual Global Growth Conference

Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, and meetings
When: Wednesday, Aug. 14 at 2:00 pm ET

A live webcast of the presentation can be accessed here.

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654 

Logo - https://mma.prnewswire.com/media/1064477/4845303/InMode_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-302214775.html

SOURCE InMode LTD

FAQ

Which investor conferences will InMode (INMD) attend in August 2024?

InMode (INMD) will attend the 9th Annual Needham Virtual MedTech & Diagnostics Conference on August 12 and the Canaccord 44th Annual Global Growth Conference on August 14, 2024.

Who will represent InMode (INMD) at the Needham Virtual MedTech & Diagnostics Conference?

CEO Moshe Mizrahy and CFO Yair Malca will represent InMode (INMD) at the Needham Virtual MedTech & Diagnostics Conference, conducting virtual one-on-one meetings.

What is the format of InMode's (INMD) presentation at the Canaccord Global Growth Conference?

InMode's (INMD) CFO Yair Malca will participate in an in-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, at the Canaccord Global Growth Conference.

When is InMode's (INMD) presentation scheduled at the Canaccord Conference?

InMode's (INMD) presentation at the Canaccord Conference is scheduled for Wednesday, August 14, 2024, at 2:00 pm ET.

Will there be a webcast of InMode's (INMD) presentation at the Canaccord Conference?

Yes, a live webcast of InMode's (INMD) presentation at the Canaccord Conference will be available for interested parties.